<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105972">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02019862</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1314</org_study_id>
    <nct_id>NCT02019862</nct_id>
  </id_info>
  <brief_title>TRJ Post Market Clinical Follow Up</brief_title>
  <official_title>TRJ PMCF Köln: 2-years Results</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical and radiological 2 years results of TRJ® Hip Stem.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Implant Survival</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcome</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Harris Hip Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osteolysis</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiological Outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ossification</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiological Outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migration</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiological Outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TRJ® Implant Position</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiological Outcome</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>TRJ®</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TRJ® Total Hip Arthroplasty</intervention_name>
    <arm_group_label>TRJ®</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        specialist clinical centre
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion:

          -  TRJ® implantation performed

          -  patient consent available for participation in the study

        Exclusion:

          -  permanent cortisone therapy

          -  alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne-Katrin Wacker</last_name>
    <phone>+49-7461-95-1509</phone>
    <email>anne_katrin.wacker@bbraun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Weiler, Dr.</last_name>
    <phone>+49-7461-95-2721</phone>
    <email>andrea.weiler@aesculap.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dreifaltigkeitskrankenhaus Köln</name>
      <address>
        <city>Köln</city>
        <zip>50933</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Höllriegl, Dr.</last_name>
      <phone>0221/94071228</phone>
      <email>stefan.hoellriegl@dfk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Steffen Sütfels, Dr.</last_name>
      <email>steffensuetfels@dfk-koeln.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 24, 2014</lastchanged_date>
  <firstreceived_date>December 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total hip arthroplasty</keyword>
  <keyword>TRJ</keyword>
  <keyword>PMCF</keyword>
  <keyword>Hip stem</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
